汉斯状联合化疗在新辅助/辅助胃癌治疗中的三期临床试验达到主要终点,为提前提交新药上市申请开绿灯

美股速递
Oct 09, 2025

汉斯状联合化疗在新辅助/辅助胃癌治疗领域的三期临床试验成功达到主要终点,这一积极结果为提前提交新药上市申请(NDA)铺平了道路。该试验结果表明,汉斯状联合化疗方案在治疗新辅助和辅助胃癌患者方面显示出良好的疗效,为胃癌患者带来了新的治疗希望。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10